How to cite this paper
Jaśkowska, J., Drabczyk, A., Kułaga, D., Zaręba, P & Majka, Z. (2018). Solvent-free microwave-assisted synthesis of aripiprazole.Current Chemistry Letters, 7(3), 81-86.
Refrences
1 Oshiro Y., Sato S., and Kurahashi N. (1988) Carbostyril derivatives. US Patent 5,006,528.
2 Gant T.G., Sarshar S., and Zhang Ch. (2008) Arylpiperazine modulators of D2 receptors, 5-HT1A receptors, and/or 5-HT2A. US Patent 20100069399.
3 Oshiro Y., Sato S., Kurahashi N., Tanaka T., Kikuchi T., Tottori K., Uwahodo Y., and Nishi T. (1998) Novel Antipsychotic Agents with Dopamine Autoreceptor Agonist Properties: Synthesis and Pharmacology of 7-[4-(4-Phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone Derivatives, J. Med. Chem. 41 (5) 658-667.
4 Tsujimori H., Yamaguchi T. (2004) Process for preparing aripiprazole. JP Patent WO2004063162.
5 Kikuchi T., Iwamoto T., and Hirose T. (2004) Carbostyril derivatives and mood stabilizers for treating mood disorders. JP Patent WO2004105682.
6 Dolitzky B.-Z., Lerman O. (2005) Process for preparing aripiprazole. US Patent 20050215791.
7 Ramakrishnan A., Subhash V.D., G. Panchal Dharmesh (2007) A novel process for preparation of aripiprazole and its intermediates. Patent WO2007094009.
8 Shah N.S., Dwivedi S.D., Maneklal K.,Vinchhi K.M. and Nadimpally S. V. R. (2008) Process for preparing crystalline aripiprazole. US Patent 2010113784.
9 Kikuchi T., Iwamoto T., Hirose T. (2003) Carbostyril derivatives and mood stabilizers for treating mood disorders. US Patent 9,125,939.
10 Koftis T.V., Soni R.R., Acharya H.H., Patel K.H., Ahirrao M.D. (2013) Process for the preparation of aripiprazole. Patent WO2013020672.
11 Gupta V.S., Kumar P. and Vir D. (2011) Process for producing aripiprazole in anhydrous type i crystals. Patent WO2012131451.
12 Shi, H., Babinski D.J. and Ritter T. (2015) Modular C–H Functionalization Cascade of Aryl Iodides, J. Am. Chem. Soc. 137 (11) 3775-3778.
13 Leś, A. Badowska-Rosłonek K., Łaszcz M., Kamieńska-Duda A., Baran P., and Kaczmarek Ł. (2010) Optimization of aripiprazole synthesis, Acta Pol. Pharm. 67 (2) 151-157.
14 Deshpande P.B., Luthra P.K., Shanishchara A.P., Manepalli R., Mistry D.B. (2007) A process for the preparation of aripiprazole. Patent WO2007113846.
15 Nagarimadugu M., Kaushik K.V., Dandala R., Meenakshisunderam S. (2010) Process for the preparation of aripiprazole US Patent 2010130744.
16 Kaczmarek Ł., Badowska-Rosłonek K., and Łaszcz M. (2007) Prosta metoda syntezy substancji farmaceutycznej aripiprazol w oczekiwanej formie polimorficznej, Przem. Chem. 86 (8) 773-776.
17 Pai N.R., Dubhashi D.S., Vishwasrao S., Pusalkar D. (2010) An efficient synthesis of neuroleptic drugs under microwave irradiation. J. Chem. Pharm. Res. 2 (5) 506-517.
18 Kowalski P., Mitka K., Jaśkowska J., Bojarski A.J. and Duszyńska B. (2013) New arypiperazines with flexible vs partly constrained linker as serotonin 5-HT1A/5-HT7 receptor ligands. Archiv der Pharm. 346 (5) 339-348.
19 Kowalski P., Jaśkowska J. (2012) An Efficient Synthesis of Aripiprazole, Buspirone and NAN-190 by the Reductive Alkylation of Amines Procedure” Archiv der Pharm. 345 (1) 81-85.
20 Kowalski P., Jaśkowska J., Bojarski A.J., Duszyńska B., and Kołaczkowski M. (2011) Evaluation of 1-arylpiperazine derivative of salicylamides as the 5-HT1A and 5-HT7 serotonin receptor ligands. J. Heterocycl. Chem. 48 (1) 192-198.
21 Kowalski P., Jaśkowska J., Bojarski A. J., and Duszyńska B. (2008) The synthesis of cyclic and acyclic long-chain arylpiperazine derivatives of salicylamide as serotonin receptor ligands. J. Heterocycl. Chem. 45 (1) 209-214.
22 Jaśkowska J., Kowalski P. (2008) N-Alkylation of imides at ambient temperature using phase transfer catalysis under solvent-free conditions. J. Heterocycl. Chem. 45 (1) 1371-1375.
23 Jaśkowska J., Kułaga D., Majka Z. (2016) Nowa bezrozpuszczalnikowa metoda syntezy olanzapiny i jej pochodnych, Przem. Chem. 95 (10) 1918-1920.
2 Gant T.G., Sarshar S., and Zhang Ch. (2008) Arylpiperazine modulators of D2 receptors, 5-HT1A receptors, and/or 5-HT2A. US Patent 20100069399.
3 Oshiro Y., Sato S., Kurahashi N., Tanaka T., Kikuchi T., Tottori K., Uwahodo Y., and Nishi T. (1998) Novel Antipsychotic Agents with Dopamine Autoreceptor Agonist Properties: Synthesis and Pharmacology of 7-[4-(4-Phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone Derivatives, J. Med. Chem. 41 (5) 658-667.
4 Tsujimori H., Yamaguchi T. (2004) Process for preparing aripiprazole. JP Patent WO2004063162.
5 Kikuchi T., Iwamoto T., and Hirose T. (2004) Carbostyril derivatives and mood stabilizers for treating mood disorders. JP Patent WO2004105682.
6 Dolitzky B.-Z., Lerman O. (2005) Process for preparing aripiprazole. US Patent 20050215791.
7 Ramakrishnan A., Subhash V.D., G. Panchal Dharmesh (2007) A novel process for preparation of aripiprazole and its intermediates. Patent WO2007094009.
8 Shah N.S., Dwivedi S.D., Maneklal K.,Vinchhi K.M. and Nadimpally S. V. R. (2008) Process for preparing crystalline aripiprazole. US Patent 2010113784.
9 Kikuchi T., Iwamoto T., Hirose T. (2003) Carbostyril derivatives and mood stabilizers for treating mood disorders. US Patent 9,125,939.
10 Koftis T.V., Soni R.R., Acharya H.H., Patel K.H., Ahirrao M.D. (2013) Process for the preparation of aripiprazole. Patent WO2013020672.
11 Gupta V.S., Kumar P. and Vir D. (2011) Process for producing aripiprazole in anhydrous type i crystals. Patent WO2012131451.
12 Shi, H., Babinski D.J. and Ritter T. (2015) Modular C–H Functionalization Cascade of Aryl Iodides, J. Am. Chem. Soc. 137 (11) 3775-3778.
13 Leś, A. Badowska-Rosłonek K., Łaszcz M., Kamieńska-Duda A., Baran P., and Kaczmarek Ł. (2010) Optimization of aripiprazole synthesis, Acta Pol. Pharm. 67 (2) 151-157.
14 Deshpande P.B., Luthra P.K., Shanishchara A.P., Manepalli R., Mistry D.B. (2007) A process for the preparation of aripiprazole. Patent WO2007113846.
15 Nagarimadugu M., Kaushik K.V., Dandala R., Meenakshisunderam S. (2010) Process for the preparation of aripiprazole US Patent 2010130744.
16 Kaczmarek Ł., Badowska-Rosłonek K., and Łaszcz M. (2007) Prosta metoda syntezy substancji farmaceutycznej aripiprazol w oczekiwanej formie polimorficznej, Przem. Chem. 86 (8) 773-776.
17 Pai N.R., Dubhashi D.S., Vishwasrao S., Pusalkar D. (2010) An efficient synthesis of neuroleptic drugs under microwave irradiation. J. Chem. Pharm. Res. 2 (5) 506-517.
18 Kowalski P., Mitka K., Jaśkowska J., Bojarski A.J. and Duszyńska B. (2013) New arypiperazines with flexible vs partly constrained linker as serotonin 5-HT1A/5-HT7 receptor ligands. Archiv der Pharm. 346 (5) 339-348.
19 Kowalski P., Jaśkowska J. (2012) An Efficient Synthesis of Aripiprazole, Buspirone and NAN-190 by the Reductive Alkylation of Amines Procedure” Archiv der Pharm. 345 (1) 81-85.
20 Kowalski P., Jaśkowska J., Bojarski A.J., Duszyńska B., and Kołaczkowski M. (2011) Evaluation of 1-arylpiperazine derivative of salicylamides as the 5-HT1A and 5-HT7 serotonin receptor ligands. J. Heterocycl. Chem. 48 (1) 192-198.
21 Kowalski P., Jaśkowska J., Bojarski A. J., and Duszyńska B. (2008) The synthesis of cyclic and acyclic long-chain arylpiperazine derivatives of salicylamide as serotonin receptor ligands. J. Heterocycl. Chem. 45 (1) 209-214.
22 Jaśkowska J., Kowalski P. (2008) N-Alkylation of imides at ambient temperature using phase transfer catalysis under solvent-free conditions. J. Heterocycl. Chem. 45 (1) 1371-1375.
23 Jaśkowska J., Kułaga D., Majka Z. (2016) Nowa bezrozpuszczalnikowa metoda syntezy olanzapiny i jej pochodnych, Przem. Chem. 95 (10) 1918-1920.